FIELD: medicine.
SUBSTANCE: invention relates to the use of compounds having the formula (I), as well as a composition containing a compound and an acceptable auxiliary means, for the prevention or treatment of non-alcoholic steatohepatitis (hereinafter – NASH).
EFFECT: compounds are developed that can be used for the prevention and/or treatment of NASH.
8 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS | 2019 |
|
RU2768828C1 |
| TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2019 |
|
RU2815647C2 |
| NALMEFEN, NALTREXONE OR DERIVATIVES THEREOF FOR USE IN TREATING (NON)-ALCOHOLIC STEATOHEPATITIS OR NON-ALCOHOLIC FATTY LIVER DISEASE | 2017 |
|
RU2717677C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHOEPATITIS | 2021 |
|
RU2803733C1 |
| PYRIDINE SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH INTERLEUKIN 1 BETA | 2019 |
|
RU2803242C2 |
| COMBINATION OF MCL-1 INHIBITOR AND TAXANE COMPOUND, THEIR APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2763544C2 |
| BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES, USEFUL AS RHO-KINASE INHIBITORS | 2009 |
|
RU2532481C2 |
| STRUCTURALLY ENHANCED OXYGEN-CONTAINING FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2820995C2 |
| METHOD OF TREATING HEPATIC FIBROSES | 2017 |
|
RU2740902C2 |
| ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
